0000950170-24-084569.txt : 20240718
0000950170-24-084569.hdr.sgml : 20240718
20240718160417
ACCESSION NUMBER: 0000950170-24-084569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240718
FILED AS OF DATE: 20240718
DATE AS OF CHANGE: 20240718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keson-Brookes Maiken
CENTRAL INDEX KEY: 0001693805
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41837
FILM NUMBER: 241124795
MAIL ADDRESS:
STREET 1: 35 OAK HILL ROAD
CITY: FAYVILLE
STATE: MA
ZIP: 01745
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mural Oncology plc
CENTRAL INDEX KEY: 0001971543
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
BUSINESS PHONE: 353 1 905 8020
MAIL ADDRESS:
STREET 1: 10 EARLSFORT TERRACE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 T380
FORMER COMPANY:
FORMER CONFORMED NAME: Mural Oncology Ltd
DATE OF NAME CHANGE: 20230403
FORMER COMPANY:
FORMER CONFORMED NAME: Pistachiovale Ltd
DATE OF NAME CHANGE: 20230329
4
1
ownership.xml
4
X0508
4
2024-07-18
0001971543
Mural Oncology plc
MURA
0001693805
Keson-Brookes Maiken
C/O MURAL ONCOLOGY PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
false
true
false
false
See Remarks
true
Ordinary Shares
2024-07-18
4
S
false
2157
3.41
D
43850
D
Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on December 22, 2023, and the sale does not represent a discretionary trade by the Reporting Person.
Includes 38,705 unvested restricted stock units.
Chief Legal Officer and Secretary
/s/ Maiken Keson-Brookes
2024-07-18